IXHL
Incannex Healthcare, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · AU
$3.64
+1.39%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.09x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.58x
- Price / sales
- 506.41x
- Price / cash flow
- -3.48x
Enterprise value
- Enterprise value
- -$30.8M
- EV / sales
- -357.97x
- EV / EBITDA
- 1.31x
- EV / EBIT
- 1.29x
- Market cap
- $43.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026